Free rides and meals tested to speed up liver cancer care for Low-Income patients

NCT ID NCT07568457

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether offering free rideshares, hotel stays, and meal delivery helps low-income liver cancer patients start treatment sooner. About 75 uninsured or underinsured adults with liver cancer will be randomly assigned to receive these social supports plus usual patient navigation, or just navigation alone. The goal is to see if removing practical barriers reduces treatment delays.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Social support program (rideshares, hotel stays, meal delivery) plus patient navigation
What this could lead to
If it works, this could show that practical support helps low-income liver cancer patients start treatment sooner.
What could go wrong
This is a small early-stage trial with only 75 people, so results may not apply to everyone. The support may not significantly change treatment timing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HCC - HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Keck Hospital of USC

    Los Angeles, California, 90033, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • LA General Medical Center

    Los Angeles, California, 90033, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • USC Norris Comprehensive Cancer Center

    Los Angeles, California, 90033, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.